The use of cytokine inhibitors, such as IL-1 receptor antagonists, TNF-α blockers, and IL-6 inhibitors, has shown potential in other inflammatory diseases, and their application in arrhythmia management is under investigation. This evidence concerns the gene IL6 and Arrhythmia.